NIT
CVS icon

NumerixS Investment Technologies’s CVS Health CVS Stock Holding History

NumerixS Investment Technologies’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-23,040
Closed -$1.71M – 1054
2019
Q4 		$1.71M Sell
23,040
-23,962
-51% -$1.68M 0.34% 56
2019
Q3 		$2.96M Buy
47,002
+36,652
+354% +$2.17M 0.77% 17
2019
Q2 		$564K Sell
10,350
-188,170
-95% -$10.1M 0.16% 154
2019
Q1 		$10.6M Buy
198,520
+149,572
+306% +$9.23M 1.42% 3
2018
Q4 		$3.19M Buy
+48,948
New +$3.65M 1.03% 12
2018
Q3 		– Sell
-6,587
Closed -$433K – 1223
2018
Q2 		$433K Buy
6,587
+1,116
+20% +$73.5K 0.1% 286
2018
Q1 		$343K Sell
5,471
-21,423
-80% -$1.54M 0.08% 267
2017
Q4 		$1.95M Buy
26,894
+24,020
+836% +$1.75M 0.44% 35
2017
Q3 		$234K Sell
2,874
-21,126
-88% -$1.67M 0.05% 471
2017
Q2 		$1.93M Sell
24,000
-128,190
-84% -$10.1M 0.28% 75
2017
Q1 		$11.9M Buy
152,190
+77,559
+104% +$6.19M 1.37% 2
2016
Q4 		$5.89M Buy
74,631
+56,399
+309% +$4.56M 0.74% 15
2016
Q3 		$1.62M Buy
+18,232
New +$1.72M 0.21% 106
2016
Q1 		– Sell
-41,578
Closed -$4.07M – 857
2015
Q4 		$4.07M Sell
41,578
-4,992
-11% -$489K 0.51% 23
2015
Q3 		$4.49M Buy
+46,570
New +$4.9M 0.51% 38

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NumerixS Investment Technologies's CVS Position: Q1 2020 in Review

NumerixS Investment Technologies sold out of CVS Health (CVS) in Q1 2020, closing a stake of 23,040 shares — an estimated $1.71M sold.

NumerixS Investment Technologies first reported a position in CVS in Q3 2015 and held it in 15 quarters. The position peaked at $11.9M in Q1 2017. 1,817 funds tracked by Wall St. Rank hold CVS as of Q1 2020.

  • NumerixS Investment Technologies reported no remaining CVS Health position as of Q1 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 23,040 CVS Health shares in Q1 2020, an estimated $1.71M.
  • NumerixS Investment Technologies first reported a position in CVS Health in Q3 2015 and held it in 15 quarters.
  • NumerixS Investment Technologies's CVS Health position peaked at $11.9M in Q1 2017.
  • 1,817 funds tracked by Wall St. Rank held CVS Health as of Q1 2020.

Based on NumerixS Investment Technologies's 13F filing for Q1 2020, filed 15 May 2020.